Page last updated: 2024-08-23

sq-11725 and Hemorrhage

sq-11725 has been researched along with Hemorrhage in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abecasis, R; Ameigeiras, B; Argonz, J; Dominguez, N; Fassio, E; Garcia, D; Isla, R; Kravetz, D; Landeira, G; Romero, G; Terg, R1
Bernardi, M; Berzigotti, A; Bracci, E; Caraceni, P; Di Micoli, A; Domenicali, M; Felline, P; Savelli, F; Trevisani, F; Zambruni, A; Zoli, M1
Campanati, L; Di Mauro, P; Gridelli, B; Langer, M; Peta, M; Pezzi, A; Pifferi, S; Prato, P; Proietti, D; Quarenghi, E1
GarcĂ­a-Tsao, G1
Bellini, B; Bighin, R; Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D1

Trials

3 trial(s) available for sq-11725 and Hemorrhage

ArticleYear
Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Spironolactone; Splanchnic Circulation; Treatment Outcome

2003
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
    Journal of hepatology, 2008, Volume: 48, Issue:3

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Hepatic Veins; Humans; Liver Cirrhosis; Male; Middle Aged; Models, Biological; Nadolol; Prognosis; Risk Factors; Ventricular Function

2008
Beta-adrenergic antagonists to prevent bleeding from esophageal varices: a risk during liver transplantation?
    Transplantation proceedings, 1994, Volume: 26, Issue:6

    Topics: Adult; Cardiac Output; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Monitoring, Intraoperative; Nadolol; Oxygen; Propranolol; Risk Factors

1994

Other Studies

2 other study(ies) available for sq-11725 and Hemorrhage

ArticleYear
Further evidence in favor of pharmacological portal pressure reduction in the prevention of variceal hemorrhage.
    Gastroenterology, 1997, Volume: 112, Issue:5

    Topics: Antihypertensive Agents; Drug Therapy, Combination; Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Prospective Studies; Randomized Controlled Trials as Topic; Sclerotherapy; Varicose Veins; Vasodilator Agents

1997
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents

2000